NIFLUMIC

Dosage : 3%
DCI :
Form :
Table : n
Laboratory :
Therapeutic Class : RHEUMATOLOGY
Under Therapeutic Class :
Shelf life : 36 mois
Presentation Officinale : T/60 GR
Hospital Presentation :
Date Officinale AMM : 18/07/1989
Date AMM Hospital :
Primary Status :
Indication : Local support treatment of sprains, treatment of post-sclerotherapy phlebitis, in case of intense inflammatory reaction.